Oncology Solutions

Oncology research in preclinical development plays a critical role in advancing cancer therapies from concept to clinic. Using a range of in vitro and in vivo models—including cell line-derived xenografts, patient-derived xenografts (PDX), and genetically engineered mouse models—researchers evaluate the efficacy, safety, and mechanisms of novel drug candidates. These studies provide essential data on tumor growth inhibition, metastasis, immune interactions, and biomarker responses, laying the groundwork for successful translation into human clinical trials. MuriPhys offers a variety of oncology solutions tailored to support each stage of preclinical development—visit our Oncology Solutions page to learn more.